Bone morphogenetic protein 9 enhances osteogenic and angiogenic responses of human amniotic mesenchymal stem cells cocultured with umbilical vein endothelial cells through the PI3K/AKT/m-TOR signaling pathway
Authors:
Open Access
- 27 November 2021
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 13 (22) , 24829-24849
Abstract
Background: Neovascularization plays an essential part in bone fracture and defect healing, constructing tissue engineered bone that targets bone regeneration. Bone morphogenetic protein 9 (BMP9) is a regular indicator that potentiates osteogenic and angiogenic differentiation of MSCs.Keywords
This publication has 74 references indexed in Scilit:
- Endothelial and perivascular cells maintain haematopoietic stem cellsNature, 2012
- Co-culture systems for vascularization — Learning from natureAdvanced Drug Delivery Reviews, 2011
- TGFβ/BMP Type I Receptors ALK1 and ALK2 Are Essential for BMP9-induced Osteogenic Signaling in Mesenchymal Stem CellsJournal of Biological Chemistry, 2010
- Osteoblast Precursors, but Not Mature Osteoblasts, Move into Developing and Fractured Bones along with Invading Blood VesselsDevelopmental Cell, 2010
- Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formationJournal of Bone and Mineral Research, 2010
- The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation ofVegfDevelopment, 2009
- BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signallingJournal of Cellular and Molecular Medicine, 2008
- Endothelium-Microenvironment Interactions in the Developing Embryo and in the AdultDevelopmental Cell, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003